Goldberg Field
@energypickle21
Давно нет активности
NQO1 polymorphisms did not impact security benefits. Bottom line Amrubicin would not increase emergency in comparison with topotecan within the second-line management of patients using SCLC. OS did not differ significantly among treatment method teams, even though a vast improvement inside Computer itself was known in people using refractory […] Перейти
Начатые темы
- К сожалению, обсуждений нет!